glp 1 rhabdomyolysis The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 Emerging Frontiers in GLP-1 Therapeutics:

10.1007/s00125-015-3518-7 138

The long-term effects of taking glutathione supplements are unknown, and there is concern that high doses of glutathione may cause adverse effects such as liver damage, kidney damage, and even skin cancer

Osimertinib after chemoradiotherapy in stage III EGFR-mutated NSCLC

For tirzepatide (Zepbound) Jastreboff and colleagues reported in the New England Journal of Medicine in 2022 that at maximal doses, the percent of individuals reporting side effects were as follows: Nausea 31.0% Diarrhea 23.0% Vomiting 12.2% Constipation 11.7% Bettge and colleagues conducted a study published in Diabetes, Obesity, and Metabolism in 2017 that showed that individuals who were taking metformin while taking a GLP-1 were more likely to have side effects, especially nausea and vomiting